More impressively, in the chronic unpredictable stress model (a more severe, clinically relevant paradigm), BPC-157 maintained effectiveness at both 4-day and 6-day assessments while imipramine 30 mg daily only became effective after prolonged treatment
With over 1 million therapies conducted worldwide, REVIV is a leader in the benefits of B12 injections and IV therapy
"Cerebral Manifestations of Vitamin-B12 Deficiency"
It is being studied in diabetic neuropathy (NERVARA Phase 2 trial), sarcoidosis, and ischemic injury models
Often referred to as the healing peptide , BPC-157 has caught the attention of athletes, biohackers, and wellness enthusiasts for its potential to speed up recovery, repair tissues, and support overall healing
These further studies may enhance the clinical applicability of CPP-CAND and contribute to the treatment of cancer and aging-related diseases